Every finding on record at Post Acute Holdings, LLC

Recertification Survey, Re-licensing Survey, and Covid-19 Focused Infection Control Survey. Tag #684 was cited as a result of the Recertification Survey. A COVID-19 Focused Infection Control Survey was conducted on 04/01/2021. The facility has implemented the CMS and Centers for Disease Control and Prevention (CDC) recommended practices to prepare for COVID-19. Census: 85

Infection control CFR(s): 484.70(b)(1)(2) Standard: Control. The HHA must maintain a coordinated agency-wide program for the surveillance, identification, prevention, control, and investigation of infectious and communicable diseases that is an integral part of the HHA's quality assessment and performance improvement (QAPI) program. The infection control program must include: (1) A method for identifying infectious and communicable disease problems; and (2) A plan for the appropriate actions that are expected to result in improvement and disease prevention. This STANDARD is not met as evidenced by: Based on record review and interview, the agency failed to track patient infections to identify trends in infection rates for 6 of 10 sampled patients (Patient #1, Patient #2, Patient #3, Patient #4, Patient #5, and Patient #10) reviewed for infection control in a total sample of 10. Findings: Review of Patient #1's Medication Record revealed Patient #1 was prescribed Cephalexin (antibiotic, used to treat infections) 500mg (milligrams) one capsule daily on 03/10/2020. Review of Patient #2's Medication Record revealed Patient #2 was prescribed, in part: Amoxcillin-Potasium Clavulante (antibiotic) 500-125mg one tablet every twelve hours for 10 days on 10/23/2020; Doxycycline Hyclate (antibiotic) 100mg one capsule twice a day for fourteen days on 11/30/2020; and Doxycycline Hyclate (antibiotic) 100mg one capsule twice a day for ten days on 04/02/2021. Review of Patient #3's Medication Record revealed Patient #3 was prescribed Ciprofloxacin HCL (hydrochloride) (antibiotic) 500mg one tablet by mouth every 12 hours for 7 days on 03/25/2021. Review of Patient #4's Medication Record revealed Patient #4 was prescribed Amikacin Sulfate (antibiotic) 700mg in 100ml (milliliter) of normal saline per intravenous (in the vein) on Monday, Wednesday, and Fridays on 01/28/2021. Review of Patient #5's Home Health Certification and Plan of Care for certification period of 03/20/2021 to 05/18/2021, revealed Patient #5 was admitted with Dapsone (medication used to treat certain types of infections)100mg one tablet daily and Acyclovir (antiviral medication) 400mg one tablet twice a day. Review of Patient #10's Home Health Certification and Plan of Care for certification period of 09/28/2020 to 11/26/2020, revealed Patient #10 was admitted with Rocephin (antibiotic) injection 1 gram IM (intermuscular, in the muscle) daily for ten days. There was no documented evidence and the agency did not present any documented evidence of the above mentioned infections being tracked for trends or that the infections were captured on any infection report. In an interview on 04/22/2021 at 1:40pm, S2DON (Director of Nursing) stated the agency was tracking and trending patients with infections if the patient was at high risk for infection such as the use of, catheters, intravenous lines, peripheral inserted central catheters, tracheostomy, or wounds. S2DON stated the agency did not track and trend infections if the patient was not high risk. S2DON further stated if a patient was admitted with antibiotics then the agency did not track and trend those infections.